Search
Achieve Life Sciences Inc
ACHVAdd to Watchlist
7.540USD
-0.300-3.83%
Close 09-08 16:00（ET）
401.44MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-09-08The current earnings forecast score of Achieve Life Sciences Inc is 8.22, ranking 151 out of 377 in the Biotechnology & Medical Research industry. The average price target is 14.00, with a high of 25.00 and a low of 10.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
13.833
Target Price
+62.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Achieve Life Sciences Inc
ACHV
11
Beigene Ltd
ONC
27
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
24
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Achieve Life Sciences Inc's price target?
Analysts forecast that Achieve Life Sciences Inc's price target is USD 14.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 10.00.
How have Achieve Life Sciences IncACHV's recent earnings per share performed?
The market expectation was USD -0.80, while Achieve Life Sciences IncACHV's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Achieve Life Sciences Inc?
Based on the ratings of Achieve Life Sciences Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.